1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
- 2007
-
Mark
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis
(
- Contribution to journal › Article